Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00440141Phase 4Completed
A Phase 4 trial of brimonidine in Glaucoma, ocular hypertension, sponsored by Allergan. Started Jul 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00440141.